 | Raloxifene, sold under the brand name Evista among others, is a medication used to prevent and treat osteoporosis in postmenopausal women and those on... 49 KB (5,045 words) - 20:01, 20 December 2023 |
 | antiestrogenic activity. Raloxifene is a SERM that is more antiestrogenic than tamoxifen; both are estrogenic in bone, but raloxifene is antiestrogenic in... 56 KB (6,397 words) - 06:15, 13 January 2024 |
Estradiol/raloxifene (E2/RLX) is a tissue-selective estrogen complex (TSEC) which was studied for potential use in menopausal hormone therapy but was never... 4 KB (206 words) - 20:13, 10 April 2024 |
 | coagulation, in contrast to estrogens and other SERMs like tamoxifen and raloxifene. A binding assay was also performed to measure the affinity of ospemifene... 15 KB (1,610 words) - 23:01, 14 April 2024 |
 | Intravenous (IV) iron sucrose Conjugated estrogens Teriparatide Naproxen Raloxifene Long acting adrenergic beta-agonists (LABAs) Hydroxymethylglutaryl-coenzyme... 19 KB (2,015 words) - 17:14, 27 February 2024 |
Antiestrogen withdrawal response (redirect from Raloxifene withdrawal syndrome) with the selective estrogen receptor modulators (SERMs) tamoxifen and raloxifene. The phenomenon indicates that these agents can somehow result in stimulation... 3 KB (293 words) - 22:58, 13 December 2023 |
| recommended for 10 years. In 2006, the large STAR clinical study concluded that raloxifene is also effective in reducing the incidence of breast cancer. Updated... 85 KB (8,561 words) - 07:12, 15 January 2024 |
 | significantly higher than reductions found with the related SERMs tamoxifen and raloxifene. In accordance, a network meta-analysis of SERMs for breast cancer prevention... 10 KB (808 words) - 04:31, 7 November 2023 |
 | infarction. In postmenopausal women, the selective estrogen receptor modulator raloxifene is occasionally administered instead of bisphosphonates. Bisphosphonates... 30 KB (3,429 words) - 02:49, 1 January 2024 |
 | conjugated estrogens), selective estrogen receptor modulators (e.g., raloxifene, bazedoxifene), and bisphosphonates (e.g., alendronic acid, risedronic... 18 KB (1,928 words) - 17:22, 29 April 2024 |
 | not increase the risk of breast cancer. Jordan's paper The Effect of Raloxifene on Risk of Breast Cancer in Postmenopausal Women: Results from the More... 26 KB (2,903 words) - 22:41, 2 December 2023 |
 | NNC 45-1506 Ormeloxifene Ospemifene Panomifene Pipendoxifene Promensil Raloxifene Rimostil (P-081) Spironolactone SS1010 Tamoxifen TAS-108 (SR-16234) Toremifene... 17 KB (1,585 words) - 19:15, 28 April 2024 |
Study of Tamoxifen and Raloxifene (STAR) is a clinical trial from the early 2000s designed determine how the drug raloxifene compares with the drug tamoxifen... 3 KB (222 words) - 21:00, 20 December 2023 |
 | the carcinogen nitrosomethylurea and is significantly more potent than raloxifene in this regard. Arzoxifene is devoid of the uterotrophic effects of tamoxifen... 6 KB (513 words) - 19:33, 28 August 2023 |
 | miroestrol) Selective estrogen receptor modulators (e.g., tamoxifen, clomifene, raloxifene) Antiestrogens (e.g., fulvestrant, ICI-164384, ethamoxytriphetol) The... 35 KB (3,818 words) - 15:00, 9 May 2024 |
 | enlargement. Selective estrogen receptor modulators (SERMs) such as tamoxifen, raloxifene, and clomifene may be beneficial in the treatment of gynecomastia but... 63 KB (6,473 words) - 04:25, 29 April 2024 |
selective estrogen receptor modulators (SERMs) like tamoxifen, clomifene, and raloxifene, the ER silent antagonist and selective estrogen receptor degrader (SERD)... 9 KB (803 words) - 11:32, 4 January 2024 |
 | NNC 45-1506 Ormeloxifene Ospemifene Panomifene Pipendoxifene Promensil Raloxifene Rimostil (P-081) Spironolactone SS1010 Tamoxifen TAS-108 (SR-16234) Toremifene... 67 KB (6,821 words) - 14:50, 18 March 2024 |
 | anastrozole) and selective estrogen receptor modulators (e.g., tamoxifen, raloxifene) can interfere with and prevent the estrogenic effects of NPP. 5α-Reductase... 23 KB (2,124 words) - 16:09, 23 December 2023 |
 | two years in women 50 to 74 years of age. The medications tamoxifen or raloxifene may be used in an effort to prevent breast cancer in those who are at... 133 KB (14,898 words) - 19:40, 5 May 2024 |
 | effect of HRT (hormone replacement therapy) with estrogens/progestins or raloxifene in postmenopausal women with osteoporosis remains to be elucidated, but... 17 KB (1,411 words) - 04:53, 3 April 2024 |
 | antagonists/inverse agonists: Pitolisant SERM (selective estrogen receptor modulators) Raloxifene Vasodilators Minoxidil Antipsychotic medications: Droperidol Haloperidol... 17 KB (1,468 words) - 15:58, 6 April 2024 |
 | estrogens, as well as selective estrogen receptor modulators (SERMs) like raloxifene, have been found to be effective in the adjunctive treatment of schizophrenia... 162 KB (15,421 words) - 05:52, 8 April 2024 |
rafivirumab (INN) rafoxanide (INN) ralitoline (INN) ralitrexed (INN) raloxifene (INN) raltegravir (USAN) ramatroban (INN) ramciclane (INN) ramelteon (USAN)... 5 KB (276 words) - 05:08, 28 April 2024 |
 | throughout the body. The most commonly prescribed SERMs are raloxifene and tamoxifen. Raloxifene exhibits oestrogen agonist activity on bone and lipids, and... 87 KB (10,004 words) - 16:12, 10 May 2024 |
 | NNC 45-1506 Ormeloxifene Ospemifene Panomifene Pipendoxifene Promensil Raloxifene Rimostil (P-081) Spironolactone SS1010 Tamoxifen TAS-108 (SR-16234) Toremifene... 149 KB (15,672 words) - 19:15, 8 May 2024 |
 | NNC 45-1506 Ormeloxifene Ospemifene Panomifene Pipendoxifene Promensil Raloxifene Rimostil (P-081) Spironolactone SS1010 Tamoxifen TAS-108 (SR-16234) Toremifene... 26 KB (2,467 words) - 20:37, 1 February 2024 |
 | menopausal symptoms. It is not recommended for osteoporosis by itself. Raloxifene, while effective in decreasing vertebral fractures, does not affect the... 120 KB (13,419 words) - 06:33, 21 April 2024 |
 | associated with the same adverse effects as NSAIDs. Daily use of tamoxifen or raloxifene reduce the risk of breast cancer in high-risk women. The benefit versus... 186 KB (20,182 words) - 06:58, 9 May 2024 |
 | found within the chemical structures of pharmaceutical drugs such as raloxifene, zileuton, and sertaconazole, and also BTCP. It is also used in the manufacturing... 5 KB (352 words) - 00:48, 14 August 2023 |